Reviews
Left ventricular assessment using speckle-tracking echocardiography in Behçet's disease: a systematic review and meta-analysis
N. Belfeki1, N. Ghriss2, F. Jebri3, G. Hatemi4, K. Serraj5, A. Bennani6
- Department of Internal Medicine and Clinical Immunology, Groupe Hospitalier Sud Île de France, Melun, France. nabil.belfeki@ghsif.fr
- Department of Internal Medicine and Clinical Immunology, Groupe Hospitalier Sud Île de France, Melun, France.
- Department of Cardiology, Polyclinics of Europe, Saint Nazaire, France.
- Department of Internal Medicine, Division of Rheumatology, Istanbul University-Cerrahpasa Hospital, Istanbul, Turkey.
- Department of Internal Medicine, University Hospital Mohammed VI, Oujda; and Immunohaematology and Cellular Therapy Laboratory, Faculty of Medicine and Pharmacy, Mohammed First University, Oujda, Morocco.
- Department of Internal Medicine, University Hospital Mohammed VI, Oujda; and Immunohaematology and Cellular Therapy Laboratory, Faculty of Medicine and Pharmacy, Mohammed First University, Oujda, Morocco.
CER19759
2026 Vol.44, N°10
PI 2153, PF 2161
Reviews
Free to view
(click on article PDF icon to read the article)
Received: 02/02/2026
Accepted : 29/04/2026
In Press: 26/10/2026
Published: 26/10/2026
Abstract
OBJECTIVES:
Behçet’s disease (BD) is a multisystem inflammatory disorder associated with increased cardiovascular morbidity. Conventional echocardiography often fails to detect early myocardial involvement. Speckle tracking echocardiography (STE) allows sensitive assessment of left ventricular (LV) myocardial deformation, particularly global longitudinal strain (GLS). The aim of this study is to systematically evaluate LV systolic function assessed by STE in BD patients and to compare GLS differences with healthy controls.
METHODS:
PubMed, Scopus and Web of Science databases were searched for studies assessing LV strain by STE in BD. Studies using two- or four-dimensional STE were included. Pooled standardised mean differences (SMD) in LV GLS between BD patients and controls were calculated using random-effects models. Heterogeneity was assessed using I2 and Cochrane Q test and was further explored using Baujat plot and leave-one-out analysis. PROSPERO registry number: CRD420251251109.
RESULTS:
Eight studies including 373 BD patients and 402 controls were included. LV GLS was not significantly reduced in BD compared to controls (SMD -0.59; 95% CI -1.21 to 0.04; p=0.06). Subgroup analyses showed that GLS impairment was more pronounced in patients with non-active disease (SMD -0.9; 95% CI -1.71 to -0.08), while no significant difference was observed in patients with no cardiovascular risk factors (p=0.20).
CONCLUSIONS:
BD patients do not exhibit consistent subclinical LV systolic dysfunction in strain echocardiography. Further studies are required to optimise the use of STE in this population.
